SciSparc (SPRC) Competitors

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

$1.29

-0.03 (-2.27%)

(As of 04/18/2024 ET)

Stock Analysis Chart Competitors Financials Headlines SEC Filings Short Interest Social Media

SPRC vs. EVLO, EVFM, BDRX, SXTC, BLPH, ATNF, ADTX, ALLR, PRFX, and NBSE

Should you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include Evelo Biosciences (EVLO), Evofem Biosciences (EVFM), Biodexa Pharmaceuticals (BDRX), China SXT Pharmaceuticals (SXTC), Bellerophon Therapeutics (BLPH), 180 Life Sciences (ATNF), Aditxt (ADTX), Allarity Therapeutics (ALLR), PainReform (PRFX), and NeuBase Therapeutics (NBSE). These companies are all part of the "pharmaceutical preparations" industry.

SciSparc vs.

SciSparc (NASDAQ:SPRC) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, community ranking, earnings, dividends and profitability.

: Company Net Margins Return on Equity Return on Assets
SciSparc N/A N/A N/A
Evelo Biosciences N/A N/A -189.58%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SciSparc
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Evelo Biosciences
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: SciSparc has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500.
: 25.1% of SciSparc shares are held by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are held by institutional investors. 1.5% of SciSparc shares are held by insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: Evelo Biosciences received 168 more outperform votes than SciSparc when rated by MarketBeat users. However, 66.67% of users gave SciSparc an outperform vote while only 60.50% of users gave Evelo Biosciences an outperform vote.
Company Underperform Outperform
SciSparc Outperform Votes
2
66.67%
Underperform Votes
1
33.33%
Evelo Biosciences Outperform Votes
170
60.50%
Underperform Votes
111
39.50%
: In the previous week, SciSparc and SciSparc both had 2 articles in the media. Evelo Biosciences' average media sentiment score of 0.32 beat SciSparc's score of 0.16 indicating that Evelo Biosciences is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SciSparc
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Evelo Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: SciSparc has higher revenue and earnings than Evelo Biosciences.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SciSparc $2.88M 0.32 -$5.12M N/A N/A
Evelo Biosciences N/A N/A -$114.53M -$13.29 0.00

Company	Net Margins	Return on Equity	Return on Assets
SciSparc	N/A	N/A	N/A
Evelo Biosciences	N/A	N/A	-189.58%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SciSparc	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Evelo Biosciences	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Underperform	Outperform
SciSparc	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%
Evelo Biosciences	Outperform Votes 170 60.50%	Underperform Votes 111 39.50%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SciSparc	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evelo Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SciSparc	$2.88M	0.32	-$5.12M	N/A	N/A
Evelo Biosciences	N/A	N/A	-$114.53M	-$13.29	0.00

Summary

SciSparc beats Evelo Biosciences on 6 of the 9 factors compared between the two stocks.

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

Get SciSparc News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SPRC vs. The Competition

Export to Excel

Metric	SciSparc	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$912,000.00	$6.40B	$4.75B	$7.44B
Dividend Yield	N/A	2.97%	2.98%	4.00%
P/E Ratio	N/A	12.85	231.05	17.68
Price / Sales	0.32	330.46	2,318.55	84.57
Price / Cash	N/A	20.94	47.14	35.12
Price / Book	0.10	5.48	4.58	4.19
Net Income	-$5.12M	$145.97M	$104.25M	$214.08M
7 Day Performance	-27.73%	-7.89%	-5.39%	-4.90%
1 Month Performance	-46.91%	-7.58%	-4.86%	-3.50%
1 Year Performance	-91.22%	-3.43%	8.42%	3.81%

SciSparc Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVLO Evelo Biosciences	0 of 5 stars	$0.05 flat	N/A	-98.4%	$873,000.00	N/A	0.00	66	Options Volume News Coverage Gap Up
EVFM Evofem Biosciences	0 of 5 stars	$0.02 flat	N/A	-99.6%	$826,000.00	$18.22M	0.00	35	Upcoming Earnings News Coverage Gap Up
BDRX Biodexa Pharmaceuticals	1.7919 of 5 stars	$0.86 +4.9%	$8.00 +829.7%	-96.4%	$1.11M	$870,000.00	0.00	27	Upcoming Earnings Positive News
SXTC China SXT Pharmaceuticals	0 of 5 stars	$1.62 +38.5%	N/A	-83.5%	$745,000.00	$1.97M	0.00	78	Gap Down High Trading Volume
BLPH Bellerophon Therapeutics	1.8116 of 5 stars	$0.05 flat	$2.00 +3,569.7%	-99.4%	$667,000.00	N/A	-0.06	18	Gap Up
ATNF 180 Life Sciences	0 of 5 stars	$1.48 -27.5%	N/A	-92.5%	$1.26M	N/A	0.00	5	Positive News Gap Down High Trading Volume
ADTX Aditxt	2.3372 of 5 stars	$2.43 -9.0%	$61.00 +2,410.3%	-93.7%	$583,000.00	$930,000.00	0.00	61	Positive News Gap Down
ALLR Allarity Therapeutics	0.1468 of 5 stars	$1.68 -16.0%	N/A	-99.8%	$521,000.00	N/A	0.00	5	Stock Split News Coverage High Trading Volume
PRFX PainReform	0 of 5 stars	$0.81 -17.3%	N/A	-86.1%	$1.40M	N/A	0.00	7	Gap Down High Trading Volume
NBSE NeuBase Therapeutics	0 of 5 stars	$0.40 -2.4%	N/A	-87.1%	$1.52M	N/A	-0.05	37	Negative News Gap Down

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:SPRC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SciSparc (SPRC) Competitors

SPRC vs. EVLO, EVFM, BDRX, SXTC, BLPH, ATNF, ADTX, ALLR, PRFX, and NBSE

SciSparc vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPRC vs. The Competition

SciSparc Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info